BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 70 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $128,274 | +2.6% | 1,190,150 | -9.7% | 0.43% | +4.1% |
Q1 2024 | $125,064 | -6.5% | 1,318,404 | -9.0% | 0.41% | -14.4% |
Q4 2023 | $133,694 | -99.8% | 1,449,414 | +157.7% | 0.48% | +250.4% |
Q4 2021 | $60,248,000 | +38.0% | 562,489 | +32.5% | 0.14% | +31.7% |
Q3 2021 | $43,654,000 | +13.3% | 424,607 | -3.1% | 0.10% | +11.8% |
Q2 2021 | $38,531,000 | -17.9% | 438,049 | -9.3% | 0.09% | -22.5% |
Q1 2021 | $46,947,000 | -28.6% | 482,846 | -17.7% | 0.12% | -31.0% |
Q4 2020 | $65,776,000 | +70.0% | 586,499 | +40.5% | 0.17% | +41.5% |
Q3 2020 | $38,684,000 | +59.6% | 417,304 | +34.3% | 0.12% | +44.7% |
Q2 2020 | $24,231,000 | +39.4% | 310,659 | +4.5% | 0.08% | +10.4% |
Q1 2020 | $17,378,000 | -59.1% | 297,169 | -43.9% | 0.08% | -45.8% |
Q4 2019 | $42,472,000 | -42.5% | 530,176 | -47.3% | 0.14% | -43.7% |
Q3 2019 | $73,888,000 | -19.8% | 1,005,683 | +3.0% | 0.25% | -15.7% |
Q2 2019 | $92,100,000 | +38.4% | 976,359 | +17.5% | 0.30% | +34.7% |
Q1 2019 | $66,529,000 | +130.5% | 831,099 | +55.2% | 0.22% | +111.4% |
Q4 2018 | $28,860,000 | -10.1% | 535,343 | +30.2% | 0.10% | +18.0% |
Q3 2018 | $32,087,000 | -38.8% | 411,061 | -50.2% | 0.09% | -41.8% |
Q2 2018 | $52,404,000 | -64.1% | 825,518 | -48.2% | 0.15% | -64.7% |
Q1 2018 | $146,085,000 | +8.6% | 1,593,079 | -10.7% | 0.43% | +13.3% |
Q4 2017 | $134,482,000 | +9.3% | 1,783,344 | +1.0% | 0.38% | +6.7% |
Q3 2017 | $122,993,000 | +40.4% | 1,765,366 | +2.1% | 0.36% | +38.1% |
Q2 2017 | $87,617,000 | +27.4% | 1,729,169 | +0.5% | 0.26% | +26.2% |
Q1 2017 | $68,793,000 | +127.0% | 1,720,266 | +59.2% | 0.21% | +123.9% |
Q4 2016 | $30,310,000 | +261.5% | 1,080,574 | +282.8% | 0.09% | +253.8% |
Q3 2016 | $8,385,000 | +96.6% | 282,303 | +34.1% | 0.03% | +100.0% |
Q2 2016 | $4,264,000 | +86.1% | 210,581 | +65.9% | 0.01% | +85.7% |
Q1 2016 | $2,291,000 | -88.4% | 126,904 | -83.1% | 0.01% | -88.3% |
Q4 2015 | $19,800,000 | +44.3% | 751,715 | +16.9% | 0.06% | +46.3% |
Q3 2015 | $13,725,000 | -29.5% | 643,162 | -12.5% | 0.04% | -19.6% |
Q2 2015 | $19,481,000 | – | 735,419 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |